SINGLE-DOSE AND FRACTIONATED-IRRADIATION OF 4 HUMAN LUNG-CANCER CELL-LINES INVITRO

被引:28
作者
BRODIN, O
LENNARTSSON, L
NILSSON, S
机构
[1] Department of Oncology, Akademiska Sjukhuset, University of Uppsala, Uppsala
关键词
LUNG CANCER; CELL LINES; INVITRO; IRRADIATION; SINGLE DOSE; FRACTIONATED DOSE; SURVIVAL CURVES;
D O I
10.3109/02841869109088251
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Four established human lung cancer cell lines were exposed to single-dose irradiation. The survival curves of 2 small cell lung carcinomas (SCLC) were characterized by a limited capacity for repair with small and moderate shoulders with extrapolation numbers (n) of 1.05 and 1.60 respectively. Two non-small cell lung carcinoma (NSCLC) cell lines, one squamous cell (SQCLC) and one large cell (L.C1.C) had large shoulders with n-values of 73 and 15 respectively. The radiosensitivity when measured as D0 did not. however, differ as much from cell line to cell line, with values from 1.22 to 1.65. The surviving fraction after 2 Gy (SF2) was 0.24 and 0.42 respectively in the SCLC, cell lines and 0.90 and 0.88 respectively in the NSCLC, cell lines. Fractionated irradiation delivered according to 3 different schedules was also investigated. All the schedules delivered a total dose of 10 Gy in 5 days and were applied in 1, 2 and 5 Gy dose fractions respectively. Survival followed the pattern found after single-dose irradiation; it was lowest in the SCLC cell line with the lowest SF and highest in the two NSCLC cell lines. In the SCLC cell lines all schedules were approximately equally efficient. In the LCLC and in the SQCLC cell lines, the 5 Gy schedule killed more cells than the 1 and 2 Gy schedules. The results indicate that the size of the shoulder of the survival curve is essential when choosing the most tumoricidal fractionation schedule.
引用
收藏
页码:967 / 974
页数:8
相关论文
共 41 条
[1]   ALTERNATING RADIOTHERAPY AND CHEMOTHERAPY SCHEDULES IN SMALL CELL LUNG-CANCER, LIMITED DISEASE [J].
ARRIAGADA, R ;
LECHEVALIER, T ;
BALDEYROU, P ;
PICO, JL ;
RUFFIE, P ;
MARTIN, M ;
ELBAKRY, HM ;
DUROUX, P ;
BIGNON, J ;
LENFANT, B ;
HAYAT, M ;
ROUESSE, JG ;
SANCHOGARNIER, H ;
TUBIANA, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (08) :1461-1467
[2]  
BERGH J, 1985, ACTA PATH MICRO IM A, V93, P133
[3]  
BERGH J, 1982, ACTA PATH MICRO IM A, V90, P149
[4]  
CARNEY DN, 1983, CANCER RES, V43, P2806
[5]  
CHOI CH, 1976, CANCER, V37, P2651, DOI 10.1002/1097-0142(197606)37:6<2651::AID-CNCR2820370612>3.0.CO
[6]  
2-G
[7]   DOSE-TIME RELATIONSHIPS AND LOCAL CONTROL OF SMALL CELL-CARCINOMA OF LUNG [J].
COX, JD ;
BYHARDT, RW ;
WILSON, JF ;
KOMAKI, R ;
EISERT, DR ;
GREENBERG, M .
RADIOLOGY, 1978, 128 (01) :205-207
[8]   THE RADIORESPONSIVENESS OF HUMAN-TUMORS AND THE INITIAL SLOPE OF THE CELL-SURVIVAL CURVE [J].
DEACON, J ;
PECKHAM, MJ ;
STEEL, GG .
RADIOTHERAPY AND ONCOLOGY, 1984, 2 (04) :317-323
[9]   THE ACUTE INVITRO AND INVIVO RADIOSENSITIVITY OF HUMAN-LUNG TUMOR LINES [J].
DUCHESNE, GM ;
PEACOCK, JH ;
STEEL, GG .
RADIOTHERAPY AND ONCOLOGY, 1986, 7 (04) :353-361
[10]   INHERENT CELLULAR RADIOSENSITIVITY AS A BASIC CONCEPT FOR HUMAN-TUMOR RADIOTHERAPY [J].
FERTIL, B ;
MALAISE, EP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1981, 7 (05) :621-629